EURORDIS welcomes key gains for patients in agreement on EU Critical Medicines Act May 2026 ++

https://www.eurordis.org/eurordis-welcomes-key-gains-in-cma-agreement/ EURORDIS welcomes key gains for patients in agreement on EU Critical Medicines Act May 2026 12 May 2026, Brussels – EURORDIS–Rare Diseases Europe today welcomes the provisional agreementreached between the European Parliament and the Council of the EU on the Critical Medicines Act (CMA), a Regulation designed to strengthen the security of supply and availability of medicines across the European Union. https://health.ec.europa.eu/medicinal-products/critical-medicines-act_en